These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 14624807)

  • 1. Dopamine phenotype and behaviour in animal models: in relation to attention deficit hyperactivity disorder.
    Viggiano D; Ruocco LA; Sadile AG
    Neurosci Biobehav Rev; 2003 Nov; 27(7):623-37. PubMed ID: 14624807
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serotonin/dopamine interactions in a hyperactive mouse: reduced serotonin receptor 1B activity reverses effects of dopamine transporter knockout.
    Hall FS; Sora I; Hen R; Uhl GR
    PLoS One; 2014; 9(12):e115009. PubMed ID: 25514162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pronounced Hyperactivity, Cognitive Dysfunctions, and BDNF Dysregulation in Dopamine Transporter Knock-out Rats.
    Leo D; Sukhanov I; Zoratto F; Illiano P; Caffino L; Sanna F; Messa G; Emanuele M; Esposito A; Dorofeikova M; Budygin EA; Mus L; Efimova EV; Niello M; Espinoza S; Sotnikova TD; Hoener MC; Laviola G; Fumagalli F; Adriani W; Gainetdinov RR
    J Neurosci; 2018 Feb; 38(8):1959-1972. PubMed ID: 29348190
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenotypic expression of the targeted null-mutation in the dopamine transporter gene varies as a function of the genetic background.
    Morice E; Denis C; Giros B; Nosten-Bertrand M
    Eur J Neurosci; 2004 Jul; 20(1):120-6. PubMed ID: 15245485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperactivity and impaired response habituation in hyperdopaminergic mice.
    Zhuang X; Oosting RS; Jones SR; Gainetdinov RR; Miller GW; Caron MG; Hen R
    Proc Natl Acad Sci U S A; 2001 Feb; 98(4):1982-7. PubMed ID: 11172062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential regulation of the dopamine D1, D2 and D3 receptor gene expression and changes in the phenotype of the striatal neurons in mice lacking the dopamine transporter.
    Fauchey V; Jaber M; Caron MG; Bloch B; Le Moine C
    Eur J Neurosci; 2000 Jan; 12(1):19-26. PubMed ID: 10651856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced midbrain dopamine transporter binding in male adolescents with attention-deficit/hyperactivity disorder: association between striatal dopamine markers and motor hyperactivity.
    Jucaite A; Fernell E; Halldin C; Forssberg H; Farde L
    Biol Psychiatry; 2005 Feb; 57(3):229-38. PubMed ID: 15691523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopamine receptors and dopamine transporter in brain function and addictive behaviors: insights from targeted mouse mutants.
    Drago J; Padungchaichot P; Accili D; Fuchs S
    Dev Neurosci; 1998; 20(2-3):188-203. PubMed ID: 9691193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct roles of dopamine D2L and D2S receptor isoforms in the regulation of protein phosphorylation at presynaptic and postsynaptic sites.
    Lindgren N; Usiello A; Goiny M; Haycock J; Erbs E; Greengard P; Hokfelt T; Borrelli E; Fisone G
    Proc Natl Acad Sci U S A; 2003 Apr; 100(7):4305-9. PubMed ID: 12651945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Behavioral, cellular and molecular consequences of the dopamine transporter gene inactivation].
    Jaber M; Bloch B; Caron MG; Giros B
    C R Seances Soc Biol Fil; 1998; 192(6):1127-37. PubMed ID: 10101608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The dopaminergic system in attention deficit/hyperactivity disorder.
    Ohno M
    Congenit Anom (Kyoto); 2003 Jun; 43(2):114-22. PubMed ID: 12893970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Locomotor hyperactivity in 14-3-3ζ KO mice is associated with dopamine transporter dysfunction.
    Ramshaw H; Xu X; Jaehne EJ; McCarthy P; Greenberg Z; Saleh E; McClure B; Woodcock J; Kabbara S; Wiszniak S; Wang TY; Parish C; van den Buuse M; Baune BT; Lopez A; Schwarz Q
    Transl Psychiatry; 2013 Dec; 3(12):e327. PubMed ID: 24301645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between blockade of dopamine transporters by oral methylphenidate and the increases in extracellular dopamine: therapeutic implications.
    Volkow ND; Wang GJ; Fowler JS; Logan J; Franceschi D; Maynard L; Ding YS; Gatley SJ; Gifford A; Zhu W; Swanson JM
    Synapse; 2002 Mar; 43(3):181-7. PubMed ID: 11793423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential psychostimulant-induced activation of neural circuits in dopamine transporter knockout and wild type mice.
    Trinh JV; Nehrenberg DL; Jacobsen JP; Caron MG; Wetsel WC
    Neuroscience; 2003; 118(2):297-310. PubMed ID: 12699766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential regulation of tyrosine hydroxylase in the basal ganglia of mice lacking the dopamine transporter.
    Jaber M; Dumartin B; Sagné C; Haycock JW; Roubert C; Giros B; Bloch B; Caron MG
    Eur J Neurosci; 1999 Oct; 11(10):3499-511. PubMed ID: 10564358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopamine transporter-dependent and -independent actions of trace amine beta-phenylethylamine.
    Sotnikova TD; Budygin EA; Jones SR; Dykstra LA; Caron MG; Gainetdinov RR
    J Neurochem; 2004 Oct; 91(2):362-73. PubMed ID: 15447669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential contributions of dopamine D1, D2, and D3 receptors to MDMA-induced effects on locomotor behavior patterns in mice.
    Risbrough VB; Masten VL; Caldwell S; Paulus MP; Low MJ; Geyer MA
    Neuropsychopharmacology; 2006 Nov; 31(11):2349-58. PubMed ID: 16855533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glutamatergic modulation of hyperactivity in mice lacking the dopamine transporter.
    Gainetdinov RR; Mohn AR; Bohn LM; Caron MG
    Proc Natl Acad Sci U S A; 2001 Sep; 98(20):11047-54. PubMed ID: 11572967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopaminergic system dysregulation in the mrsk2_KO mouse, an animal model of the Coffin-Lowry syndrome.
    Marques Pereira P; Gruss M; Braun K; Foos N; Pannetier S; Hanauer A
    J Neurochem; 2008 Dec; 107(5):1325-34. PubMed ID: 18823370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Methylphenidate down-regulates the dopamine receptor and transporter system in children with attention deficit hyperkinetic disorder (ADHD).
    Vles JS; Feron FJ; Hendriksen JG; Jolles J; van Kroonenburgh MJ; Weber WE
    Neuropediatrics; 2003 Apr; 34(2):77-80. PubMed ID: 12776228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.